P53 gene mutation analysis in tumors of patients exposed to α-particles

Carcinogenesis

Volumn 18, Issue 3, 1997, Pages 511-516

  Hollstein, Monica ^a   Bartsch, Helmut ^a   Wesch, Horst ^a   Kure, Elin H ^b   Mustonen, Riitta ^e   Mühlbauer, Karl Rudolf ^a   Spiethoff, Andreas ^c   Wegener, Kurt ^c   Wiethege, Thorsten ^d   Müller, Klaus Michael ^d  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b TELEMARK HOSPITAL   (Norway)

^c KLINIKUM LUDWIGSHAFEN   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

^e ACADEMY OF FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; METHIONINE; PROTEIN P53; THORIUM DIOXIDE;

ADULT; AGED; ALPHA RADIATION; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; EXON; GENE MUTATION; GERMANY; HUMAN; HUMAN TISSUE; LIVER CANCER; LUNG CANCER; POINT MUTATION; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; TUMOR SUPPRESSOR GENE; URANIUM MINE;

AGED; AGED, 80 AND OVER; ALPHA PARTICLES; CODON; CONTRAST MEDIA; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; EXONS; GENES, P53; GERMANY; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MINING; NEOPLASMS, RADIATION-INDUCED; OCCUPATIONAL DISEASES; POINT MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RADON; SMOKING; THORIUM DIOXIDE; URANIUM;

EID: 0031408144     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.3.511     Document Type: Article

References (31)

1. Greeenblatt, M.S., Bennett, W.P, Hollstein, M. and Harris, C.C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
2. Esteve, A., Sørlie, T., Martel-Planche, G., Hollstein, M., Kusters, I., Lewalter, J., Vineis, P., Sephan-Odenthal, M. and Montesano, R. (1995) Screening for p53 gene mutations in archived tumors of workers occupationally exposed to carcinogens: examples from analysis of bladder tumors. J. Occup. Environ. Med., 37, 59-68.
3. Taylor, J.A., Watson, M.A., Devereux, T.R., Michels, R.Y., Saccomanno, G., Anderson, M. (1994) p53 mutation hotspot in radon-associated lung cancer. Lancet, 343, 86-87.
4. Schüttmann, W. (1993) Schneeberg lung disease and uranium mining in the Saxon ore mountains (Erzgebirge). Am. J. Indust. Med., 23, 355-368.
5. Sidransky, D. and Hollstein, M. (1996) Clinical implications of the p53 gene. Annu. Rev. Med., 47, 285-301.
6. Jacobi, W. and Roth, P. (1995) Risiko und Verursachungswahrscheinlichkeit von extrapulmonalen Krebserkrankungen durch die berufliche Strahlen-exposition von Beschäftigten der ehemaligen Wismut AG. GSF Forschungsbericht, Oberschleiβheim, Germany.
7. Esteve, A., Lehman, T., Jiang, W., Weinstein, I.B., Harris, C.C., Ruol, A., Peracchia, A., Montesano, R. and Hollstein, M. (1993) Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of mdm2 amplification in human esophageal carcinomas. Mol. Carcinogen., 8, 306-311.
8. Lehman, T.A. et al. (1991) p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res., 51, 4090-4096.
9. Bartsch, H., Hollstein, M., Mustonen, R., Schmidt, J., Spiethoff, A., Wesch, H., Wiethege, T. and Müller, K.-M. (1995) Screening for putative radon-specific p53 mutation hotspot in German uranium miners. Lancet, 346, 121.
10. Permana, P.A. and Snapka, R. M. (1994) Aldehyde-induced protein-DNA crosslinks disrupt specific stages of SV40 DNA replication. Carcinogenesis, 15, 1031-1036.
11. Crisan, D. and Mattson, J.C. (1993) Retrospective DNA analysis using fixed tissue specimens. DNA Cell Biol., 12, 455-464.
12. Hollstein, M., Shomer, B., Greenblatt, M., Soussi, T., Hovig, E., Montesano, R. and Harris, C.C. (1996) Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res., 24, 141-146.
13. Hamelin, R., Jego, N., Laurent-Puig, P., Vidaud, M. and Thomas, G. (1993) Efficient screening of p53 mutations by denaturing gradient gel electrophoresis in colorectal tumors. Oncogene, 8, 2213-2220.
14. Renault, B., van den Broek, M., Fodde, R., Wijnen, J., Pellegata, N.S., Amadori, D., Khan, P.M. and Ranzani, G.N. (1993) Base transitions are the most frequent genetic changes at p53 in gastric cancer. Cancer Res., 53, 2614-2617.
15. Takeshima, Y., Seyama, T., Bennett, W.P., Akiyama, M., Tokuoka, S., Inai, K., Mabuchi, K., Land, C.E. and Harris, C.C. (1993) p53 mutations in lung cancers from non-smoking atomic-bomb survivors. Lancet, 342, 1520-1521.
16. Goodhead, D.T. (1994) Initial events in the cellular effects of ionizing radiations: clustered damage in DNA. Int. J. Radiat. Biol., 65, 7-17.
17. Jostes, R.F., Fleck, E.W., Morgan, T.L., Stiegler, G.L. and Cross, F.T. (1994) Southern blot and polymerase chain reaction exon analyses of HPRT-mutations induced by radon and radon progeny. Radiat. Res., 137, 371-379.
18. Ootsuyama, A., Makino, H., Nagao, M, Ochiai, A., Yamauchi, Y. and Tanooka, H. (1994) Frequent p53 mutation in mouse tumors induced by repeated β-irradiation. Mol. Carcinogen., 11, 236-242.
19. Kelly, G., Stegelmeier, B.L. and Hahn, F.F. (1995) p53 alterations in plutonium-induced F344 rat lung tumors. Radiat. Res., 142, 263-269.
20. Grosovsky, A.J., de Boer, J.G., de Jong, P.J., Drobetsky, E.A. and Glickman, B.W. (1988) Base substitutions, frameshifts, and small deletions constitute ionizing radiation-induced point mutations in mammalian cells. Proc. Natl Acad. Sci. USA, 85, 185-188.
21. Vähäkangas, K.H., Samet, J.M., Metcalf, R.A., Welsh, J.A., Bennett, W.P., Lane, D.P. and Harris, C.C. (1992) Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet, 339, 576-579.
22. Lo, Y.M.D., Darby, S., Noakes, L., Whitley, E., Silcocks, P.B.S., Fleming, K.A. and Bell, J.I. (1995) Screening for codon 249 p53 mutation in lung cancer associated with domestic radon exposure. Lancet, 345, 60.
23. McDonald, J.W., Taylor, J.A., Watson, M.A., Saccomanno, G. and Devereux, T.R. (1995) p53 and K-ras in radon-associated lung adenocarcinoma. Cancer Epidemiol. Biomarkers Prevent., 4, 791-793.
24. Venitt, S. and Biggs, P.J. (1994) Radon, mycotoxins, p53, and uranium mining. Lancet, 343, 795.
25. Srám, R., Dobiás, L., Rossner, P., Veselá, D., Vesely, D., Rakusová, R. and Rericha, V. (1993) Monitoring genotoxic exposure in uranium mines. Environ. Hlth Perspect., 101 (suppl. 3), 155-158.
26. Andersson, M., Jönsson, M., Nielsen, L.L., Vyberg, M., Visfeldt, J., Storm, H.H. and Wallin, H. (1995) Mutations in the tumor suppressor gene p53 in human liver cancer induced by α-particles. Cancer Epidemiol. Biomarkers Prevent., 4, 765-770.
27. Soini, Y., Welsh, J.A., Ishak, K.G. and Bennett, W.P. (1995) p53 mutations in primary tumors not associated with vinyl chloride exposure. Carcinogenesis, 16, 2879-2881.
28. Andersson, M. et al. (1995) Lung carcinoma and malignant mesothelioma in patients exposed to Thorotrast: incidence, histology and p53 status. Int. J. Cancer, 63, 330-336.
29. Hollstein, M., Marion, M.-J., Lehman, T., Welsh, J., Harris, C.C., Martel-Planche, G., Kusters, I., and Montesano, R. (1994) p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers. Carcinogenesis, 15, 1-3.
30. Cha, R.S. and Thilly, W.G. (1993) Specificity, efficiency, and fidelity of PCR. PCR Methods Applicat., 3, S18-29.
31. Jostes, R.F. (1996) Genetic, cytogenetic, and carcinogenic effects of radon: a review. Mutat. Res., 340, 125-139.